No images? Click here
30 September 2022
Anopheles stephensi has the capacity to thrive in urban areas, setting it apart from the other main mosquito vectors of malaria. Native to parts of South Asia and the Arabian Peninsula, it has been detected over the last decade in 5 countries in the African continent. A new WHO initiative aims to stop its further spread.
While Anopheles stephensi could pose a threat to anti-malaria efforts in Africa, more data and research are needed to determine when, where and how these mosquitoes are moving across the continent. Read what WHO experts and leading researchers have to say about the spread of this invasive malaria vector in the African continent.
WHO’s malaria guidance can be accessed through several new digital platforms: MAGICapp, a mobile app and animated videos. By responding to this survey, you can help us determine whether these platforms are meeting your needs.
In addition to RTS,S/AS01, the first malaria vaccine recommended by WHO, a healthy market of new and improved vaccines will be vital in global efforts to reduce the malaria burden and achieve elimination. WHO recently published a new document that articulates the preferred product characteristics (PPCs) and clinical development considerations for new malaria vaccines.
The 22nd meeting of the Malaria Policy Advisory Group (MPAG) will be held on 11–13 October 2022. A provisional agenda is available on the WHO website, and registration for the open sessions of the meeting will close on 7 October.
